Opthea Ltd

CKDXF Biotech & pharma

Develops drugs for wet age-related macular degeneration.

Jun 2025Revenue $25.0K/yrExpenses $156M/yr
No trendCash runway ≈ 4 months from Jun 2025
Figures by year

When will Opthea be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2025, revenue was $25.0K and expenses $156M.

Fiscal year toRevenueExpensesOperating profit
Jun 2025$25.0K$156M−$156M
Jun 2024$125K$192M−$192M
Jun 2023$108K$150M−$150M
Jun 2022$90.7K$96.6M−$96.5M